Literature DB >> 23161268

Orally administered phosphatidic acids and lysophosphatidic acids ameliorate aspirin-induced stomach mucosal injury in mice.

Tamotsu Tanaka1, Katsuya Morito, Masafumi Kinoshita, Mayumi Ohmoto, Mai Urikura, Kiyoshi Satouchi, Akira Tokumura.   

Abstract

BACKGROUND: Recent investigations revealed that lysophosphatidic acid (LPA), a phospholipid with a growth factor-like activity, plays an important role in the integrity of the gastrointestinal tract epithelium. AIM: This paper attempts to clarify the effect of orally administered phosphatidic acid (PA) and LPA on aspirin-induced gastric lesions in mice.
MATERIALS AND METHODS: Phospholipids, a free fatty acid, a diacylglycerol and a triglyceride at 1 mM (5.7 μmol/kg body weight) or 0.1 mM were orally administered to mice 0.5 h before oral administration of aspirin (1.7 mmol/kg). The total length of lesions formed on the stomach wall was measured as a lesion index. Formation of LPA from PA in the mouse stomach was examined by in vitro (in stomach lavage fluid), ex vivo (in an isolated stomach) and in vivo (in the stomach of a living mouse) examinations of phospholipase activity.
RESULTS: Palmitic acid, dioleoyl-glycerol, olive oil and lysophosphatidylcholine did not affect the aspirin-induced lesions. In contrast, phosphatidylcholine (1 mM), LPA (1 mM) and PA (0.1, 1 mM) significantly reduced the lesion index. Evidence for formation of LPA from PA in the stomach by gastric phospholipase A2 was obtained by in vitro, ex vivo and in vivo experiments. An LPA-specific receptor, LPA2, was found to be localized on the gastric surface-lining cells of mice.
CONCLUSION: Pretreatment with PA-rich diets may prevent nonsteroidal anti-inflammatory drug-induced stomach ulcers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161268     DOI: 10.1007/s10620-012-2475-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Quantification of phosphatidic acid in foodstuffs using a thin-layer-chromatography-imaging technique.

Authors:  Tamotsu Tanaka; Ayaka Kassai; Mayumi Ohmoto; Katsuya Morito; Yoshiki Kashiwada; Yoshihisa Takaishi; Mai Urikura; Jun-ichi Morishige; Kiyoshi Satouchi; Akira Tokumura
Journal:  J Agric Food Chem       Date:  2012-04-16       Impact factor: 5.279

2.  Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.

Authors:  S Somasundaram; S Rafi; J Hayllar; G Sigthorsson; M Jacob; A B Price; A Macpherson; T Mahmod; D Scott; J M Wrigglesworth; I Bjarnason
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

3.  Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress.

Authors:  Mika Adachi; Gou Horiuchi; Natsuki Ikematsu; Tamotsu Tanaka; Junji Terao; Kiyoshi Satouchi; Akira Tokumura
Journal:  Dig Dis Sci       Date:  2011-02-06       Impact factor: 3.199

Review 4.  Biological roles of lysophosphatidic acid signaling through its production by autotaxin.

Authors:  Shinichi Okudaira; Hiroshi Yukiura; Junken Aoki
Journal:  Biochimie       Date:  2010-04-22       Impact factor: 4.079

5.  Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis.

Authors:  Wenlin Deng; Louisa Balazs; De-An Wang; Lester Van Middlesworth; Gabor Tigyi; Leonard R Johnson
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

6.  Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.

Authors:  Donghong He; Viswanathan Natarajan; Randi Stern; Irina A Gorshkova; Julian Solway; Ernst Wm Spannhake; Yutong Zhao
Journal:  Biochem J       Date:  2008-05-15       Impact factor: 3.857

7.  Rapid healing of peptic ulcers in patients receiving fresh cabbage juice.

Authors:  G CHENEY
Journal:  Calif Med       Date:  1949-01

Review 8.  Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers.

Authors:  C Musumba; D M Pritchard; M Pirmohamed
Journal:  Aliment Pharmacol Ther       Date:  2009-07-03       Impact factor: 8.171

9.  Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats.

Authors:  B S Dunjic; J Axelson; A Ar'Rajab; K Larsson; S Bengmark
Journal:  Scand J Gastroenterol       Date:  1993-01       Impact factor: 2.423

10.  Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions.

Authors:  Chunying Li; Keanna S Dandridge; Anke Di; Kevin L Marrs; Erica L Harris; Koushik Roy; John S Jackson; Natalia V Makarova; Yuko Fujiwara; Patricia L Farrar; Deborah J Nelson; Gabor J Tigyi; Anjaparavanda P Naren
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

View more
  8 in total

1.  Role of phospholipids in protection of the GI mucosa.

Authors:  Lenard M Lichtenberger
Journal:  Dig Dis Sci       Date:  2013-04       Impact factor: 3.199

Review 2.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

3.  New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity.

Authors:  Noriyasu Ohshima; Takahiro Kudo; Yosuke Yamashita; Stefania Mariggiò; Mari Araki; Ayako Honda; Tomomi Nagano; Chiaki Isaji; Norihisa Kato; Daniela Corda; Takashi Izumi; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2014-12-20       Impact factor: 5.157

4.  Daily Intake of High-Fat Diet with Lysophosphatidic Acid-Rich Soybean Phospholipids Augments Colon Tumorigenesis in Kyoto Apc Delta Rats.

Authors:  Toshihiko Tsutsumi; Manami Inoue; Yoko Okamoto; Akira Ishihara; Akira Tokumura
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

Review 5.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

6.  Anti-Inflammatory and Antinociceptive Activities of Anthraquinone-2-Carboxylic Acid.

Authors:  Jae Gwang Park; Seung Cheol Kim; Yun Hwan Kim; Woo Seok Yang; Yong Kim; Sungyoul Hong; Kyung-Hee Kim; Byong Chul Yoo; Shi Hyung Kim; Jong-Hoon Kim; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2016-01-03       Impact factor: 4.711

7.  Activity of Brucea javanica oil emulsion against gastric ulcers in rodents.

Authors:  Qian Li; Linglong Yang; Linlin Fan; Chen Liang; Qiujv Wang; Huimin Wen; Jinwei Dai; Xin Li; Yuyang Zhang
Journal:  Asian J Pharm Sci       Date:  2017-12-08       Impact factor: 6.598

Review 8.  Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.

Authors:  Lidiya V Boldyreva; Maryana V Morozova; Snezhanna S Saydakova; Elena N Kozhevnikova
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.